APA (7th ed.) Citation

F, M., M, D. L., G, T., F, S., C, C., M, R., . . . I, A. (2026). A novel GMP-manufactured medicinal product candidate composed of NK and γδ T cells as adjunct immunotherapy for hematopoietic stem cell transplantation. Cell transplantation, 35, 9636897251374248. https://doi.org/10.1177/09636897251374248

Chicago Style (17th ed.) Citation

F, Morandi, Della Lastra M, Tripodi G, Sabatini F, Cocco C, Risso M, Gramignoli R, Zara F, and Airoldi I. "A Novel GMP-manufactured Medicinal Product Candidate Composed of NK and γδ T Cells as Adjunct Immunotherapy for Hematopoietic Stem Cell Transplantation." Cell Transplantation 35 (2026): 9636897251374248. https://doi.org/10.1177/09636897251374248.

MLA (9th ed.) Citation

F, Morandi, et al. "A Novel GMP-manufactured Medicinal Product Candidate Composed of NK and γδ T Cells as Adjunct Immunotherapy for Hematopoietic Stem Cell Transplantation." Cell Transplantation, vol. 35, 2026, p. 9636897251374248, https://doi.org/10.1177/09636897251374248.